Keywords: Multiple sclerosis; Pharmaceutical reimbursement, Decision-making; CHMP; committee for medicinal for human use; ICER; incremental cost-effectiveness ratio; MCID; minimal clinically important difference; MS; multiple sclerosis; PBAC; pharmaceutical benefit
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 5â²AMP; 5â² adenosine monophosphate; ADO; adenosine; DSAs; anti-donor specific antibodies; APC; antigen-presenting cell; CXCL-9; chemokine (C-X-C motif) ligand 9; cAMP; cyclic adenosine monophosphate; CTLA4; cytotoxic T-lymphocyte associated protein 4;
Keywords: AUC; area under the curve; CE; cost effectiveness; CEAC; cost-effectiveness acceptability curve; CI; confidence interval; DMSIC; Drug and Medical Supply Information Center; DRG; diagnosis-related group; DSA; deterministic sensitivity analysis; EGFR; epide
Keywords: CI; confidence interval; CMDVI; comparative modeling of dengue vaccine impact; DALY; disability-adjusted life year; GBD; global burden of disease; ICER; incremental cost-effectiveness ratio; WHO; World Health Organization;
Keywords: SB; Synaptic Bodies; SR; Synaptic Ribbons; SS; Synaptic Spherules; ISB; Intermediate Synaptic Bodies; TSB; Triangular Synaptic Bodies; RSB; Rectangular Synaptic Bodies; CAZ; Cytomatrix Active Zone; CtBP1; C-Terminal Binding Protein 1; KIF3A; Kinesin Famil
Keywords: cost-effectiveness analysis; cost-effectiveness threshold; ICER; Irish health care; waiting list;
Keywords: abatacept; ACPA; adalimumab; cost effectiveness; economic model; ICER; QALY; rheumatoid arthritis; treatment costs;
Keywords: CF; cystic fibrosis; CFTR; cystic fibrosis transmembrane conductance regulator; CRD; Centre of Research and Dissemination; DNA; deoxyribonucleic acid; HAS; Haute Autorité de Santé; HTA; health technology assessment; ICER; incremental cost effectiveness
Keywords: Influenza; Cost-effectiveness; Vaccination; Trivalent; Quadrivalent; Dynamic transmission model; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; HIV; human immunodeficiency virus; IBS; individual based simulation; I$; internationa
Keywords: Bibliotherapy; Cognitive behaviour therapy; Cost effectiveness; Health anxiety; Illness anxiety disorder; Internet therapy; Somatic symptom disorder; BIB-CBT; cognitive behavioural bibliotherapy; EQ-5D; EuroQol 5D; G-ICBT; therapist-guided internet cognit
Keywords: Helicobacter pylori; Neoplasm; Precancer; Preneoplasia; AG; atrophic gastritis; CRC; colorectal cancer; EGD; esophagogastroduodenoscopy; ESD; endoscopic submucosal dissection; GA; gastric adenocarcinoma; ICER; incremental cost-effectiveness ratio; IM; int
Keywords: Oral nutritional supplements; Dietary advice; Care home; Cost-effectiveness; QALY; ICER;
Keywords: ICER; incremental cost-effectiveness ratio; LAMS; lumen-apposing metal stent; LOS; length of stay; PS; plastic stent; PCD; percutaneous drainage; WON; walled-off necrosis; WTP; willingness to pay;
Keywords: Clomiphene citrate; Cost-effectiveness; Human menopausal gonadotrophin; ICER; Intrauterine insemination;
Keywords: CEAC; cost-effectiveness acceptability curves; CXR; chest x-ray; DW; disability weight; GBD; global burden of disease; GDP; gross domestic product; ICER; incremental cost effectiveness ratio; LDCT; low-dose computed tomography; NLST; National Lung Screeni
Keywords: Advanced Liver Disease; Mortality; Portal Hypertension; Comparison; DRG; diagnosis-related group; HCUP; Healthcare Cost and Utilization Project; HE; hepatic encephalopathy; ICER; incremental cost-effectiveness ratio; LVP+A; serial large volume paracentesi
Keywords: AAA; abdominal aortic aneurism; CTC; colonography; CS; colonoscopy; CRC; colorectal cancer; CEA; cost-effective analysis; CER; cost-effectiveness ratios; FAP; familial polyposis; FOBT; faecal-occult-blood tests; GDP; gross-domestic product; HNPCC; heredit
Keywords: Obsessive-compulsive disorder; Deep brain stimulation; Economic evaluation; Psychiatry; CBT; cognitive behavioral therapy; ICER; incremental cost-effectiveness ratio; IPG; implantable pulse generator; OCD; obsessive-compulsive disorder; QALY; Quality adju
Keywords: CAD; coronary artery disease; CCTA; coronary computed tomographic angiography; ECHO; echocardiogram; ETT; exercise treadmill testing; ICA; invasive coronary angiography; ICER; incremental cost-effectiveness ratio; MPS; myocardial perfusion scintigraphy; S
Keywords: CT; computed tomography; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; EQ-5D; EuroQol five-dimension questionnaire; EYLL; expected years of life lost; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; NCKUH
Keywords: Pneumococcal conjugate vaccine; Cost-effectiveness; Mongolia; Vaccine; Budget impact; PCV13; AMC; advance market commitment; AOM; acute otitis media; CFR; case-fatality risk; DALY; disability-adjusted life year; GDP; gross domestic product; GNI; gross nat
Keywords: ARIAS; automated diabetic retinopathy image assessment system; CE; Conformité Européenne; CI; confidence interval; DR; diabetic retinopathy; ICER; incremental cost-effectiveness ratio; M0; no maculopathy; M1; maculopathy; NHS DESP; National Health Servi
Keywords: ear infection; acute otitis media; cost; utility; watchful waiting; cost effectiveness; delayed prescription; AOM; Acute otitis media; AOM-SOS scale; Acute Otitis Media Severity of Symptom Scale; DP; Delayed prescription; ICER; Incremental cost-effectiven
Keywords: CAD; computer-aided-detection; DCIS; ductal carcinoma in situ; FNAC; fine-needle aspiration cytology; ICER; incremental cost-effectiveness ratio; NHS-EED; Economic Evaluation Database produced by the NIHR Centre for Reviews and Dissemination (CRD) at the
Keywords: Peanut oral immunotherapy; Cost-effectiveness analysis; FAQL-PF; Food Allergy Quality of Life-Parent Form; ICER; Incremental cost-effectiveness ratio; OIT; Oral immunotherapy; POIT; Peanut oral immunotherapy; QALY; Quality-adjusted life-year; QOL; Quality
Keywords: CAN$; Canadian dollars; CXL; collagen cross-linking; DALK; deep anterior lamellar keratoplasty; ICER; incremental cost-effectiveness ratio; PKP; penetrating keratoplasty; QALY; quality-adjusted life year;
Keywords: cost-effectiveness; mediastinal lymph node staging; EBUS-TBNA; mediastinoscopy; CAD; Canadian dollar; CRMM; cancer risk management model; EBUS-TBNA; endobronchial ultrasound transbronchial needle aspiration; ICER; incremental cost effectiveness ratio; LN;
Keywords: Cost Effectiveness; Budget Impact; Public Health; Health Care Expenses; CEA; cost-effectiveness analysis; CHEERS; The Consolidated Health Economic Evaluation Reporting Standards; DAA; direct-acting antiviral; HCV; hepatitis C virus; ICER; incremental cost
Keywords: Diabetes; Obesity; Low-carbohydrate diet; Shared medical appointments; Comparative effectiveness; Health services research; BMI; body mass index; BP; blood pressure; CDE; certified diabetes educator; DMC; Data Monitoring Committee; EHR; electronic health
Keywords: ACER; average cost-effectiveness ratio; CT; computerized tomography; ICER; incremental cost-effectiveness ratio; LDCT; low dose computerized tomography; LYs; life years; NLST; national lung screening trial; QALYs; quality adjusted life years; Lung cancer;
Keywords: EE; economic evaluation; OECD; Organization for Economic Co-operation and Development; CEA; cost-effectiveness analysis; CER; cost-effectiveness ratio; ICER; incremental cost-effectiveness ratio; WTP; willingness to pay; NICE; National Institute for Healt
Keywords: EQ-5D; EuroQol-5 Dimension; ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life year; QOL; quality of life; SF-36; Short-Form 36; VM; venous malformation;
Keywords: urology; venous thrombosis; pulmonary embolism; cost-benefit analysis; prevention & control; ACCP; American College of Chest Physicians; ASCO; American Society of Clinical Oncology; DVT; deep vein thrombosis; EDP; extended duration prophylaxis; ICER; incr
Keywords: Cost-utility analysis; Costs; Economics; Rehabilitation; Spinal cord decompression; Spinal cord injury; Spine surgery; Timing; Trauma; Utility; AIS; American Spinal Injury Association Impairment Scale; ICER; Incremental cost-effectiveness ratio; OMHLTC; O
Keywords: ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life-year; ITC; indirect treatment comparison; Chronic lymphocytic leukaemia; Obinutuzumab; Chlorambucil; Rituximab; Ofatumumab; Cost-effectiveness; Costs;
Keywords: Pap; Papanicolaou; HR; high-risk; HPV; human papillomavirus; LR; low risk; PHU; public health unit; MOHLTC; Ontario Ministry of Health and Long-Term Care; QALY; quality-adjusted life years; HSIL; high-grade cervical squamous intraepithelial lesion; CIN; c
Keywords: DME; diabetic macular edema; DR; diabetic retinopathy; FP; family physician; ICER; incremental cost-effectiveness ratio; NPDR; nonproliferative diabetic retinopathy; PDR; proliferative diabetic retinopathy; QALY; quality-adjusted life-year; SiDRP; Singapo
Keywords: Cost-effectiveness; ICER; INB; GPQ; Skewed data;
Keywords: AIPT; advanced interventional pain therapy; CRPS; complex regional pain syndrome; DPN; diabetic peripheral neuropathy; DRG; dorsal root ganglion; FBSS; failed back surgery syndrome; FDA; Food and Drug Administration; IDDS; intrathecal drug delivery system
Keywords: MNP; microneedle patch; QALY; quality-adjusted life years; ICER; incremental cost-effectiveness ratio; SEIR; susceptible-exposed-infectious-recovered; BTC; behind-the-counter; WTP; willingness-to-pay; Microneedle patch; Influenza; Influenza vaccination; E
Keywords: CABG; cost effectiveness; PCI; quality of life; stent(s); ASCERT; American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies; CABG; coronary artery bypass g
Keywords: Economic evaluation; Modeling; QALY; Intractable epilepsy; Ketogenic diet; Vagus nerve stimulation; KD; ketogenic diet; VNS; vague nerve stimulation; CAU; care as usual; QALY; quality adjusted life years; ICER; incremental cost-effectiveness ratio; CEAC;
Keywords: Palliative; Malignancy; Parenteral; Nutrition; Cost-effectiveness; ICER;
Keywords: GP; general practitioner; PN; practice nurse; NRT; nicotine replacement therapy; SGE; Eindhoven Corporation of Primary Health Care Centres; CO; carbon monoxide; MI; Motivational Interviewing; MEMS®; Medication Event Monitoring System; ICER; incremental c
Keywords: ICER; PPI; Antibody; Screening; CD; celiac disease; CPT; Current Procedural Terminology; DGP; deamidated gliadin peptide antibodies; EGD; esophagogastroduodenoscopy; EMA; endomysial antibodies; GERD; gastroesophageal reflux disease; GFD; gluten-free diet;
Keywords: medico-economic evaluation; cost-effectiveness ratio; benchmarks; acceptability threshold; ASMR/ASA; medical benefit provided/improvement of the expected benefit (amélioration du service médical rendu/amélioration du service attendu); CEPS; Economic Co
Keywords: CT-FNA; computed tomography-guided fine-needle aspiration; FDG-PET; 18F-fluoro-deoxyglucose positron emission tomography; ICER; incremental cost-effectiveness ratio; NB; navigation bronchoscopy; QALYs; quality-adjusted life years; VATS; video-assisted tho
Keywords: cataract; CEA; cost-effectiveness analysis; ICER; incremental cost effectiveness ratio; intraocular lens; IOL; visual performance;
Keywords: AEFI; Adverse events following immunization; CCC; Complex chronic condition; CFR; Case fatality ratio; hSBA; Human serum bactericidal assay; ICER; Incremental cost-effectiveness ratio; IMD; Invasive meningococcal disease; IMPACT; Immunization Monitoring P
Keywords: AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER